1. Home
  2. CRBU vs NC Comparison

CRBU vs NC Comparison

Compare CRBU & NC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • NC
  • Stock Information
  • Founded
  • CRBU 2011
  • NC 1913
  • Country
  • CRBU United States
  • NC United States
  • Employees
  • CRBU N/A
  • NC N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • NC Coal Mining
  • Sector
  • CRBU Health Care
  • NC Energy
  • Exchange
  • CRBU Nasdaq
  • NC Nasdaq
  • Market Cap
  • CRBU 236.3M
  • NC 232.4M
  • IPO Year
  • CRBU 2021
  • NC N/A
  • Fundamental
  • Price
  • CRBU $1.98
  • NC $32.27
  • Analyst Decision
  • CRBU Strong Buy
  • NC
  • Analyst Count
  • CRBU 3
  • NC 0
  • Target Price
  • CRBU $14.00
  • NC N/A
  • AVG Volume (30 Days)
  • CRBU 1.9M
  • NC 12.9K
  • Earning Date
  • CRBU 11-06-2024
  • NC 10-30-2024
  • Dividend Yield
  • CRBU N/A
  • NC 2.97%
  • EPS Growth
  • CRBU N/A
  • NC N/A
  • EPS
  • CRBU N/A
  • NC N/A
  • Revenue
  • CRBU $11,475,000.00
  • NC $224,047,000.00
  • Revenue This Year
  • CRBU N/A
  • NC N/A
  • Revenue Next Year
  • CRBU N/A
  • NC N/A
  • P/E Ratio
  • CRBU N/A
  • NC N/A
  • Revenue Growth
  • CRBU N/A
  • NC 1.12
  • 52 Week Low
  • CRBU $1.50
  • NC $25.19
  • 52 Week High
  • CRBU $8.33
  • NC $38.66
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 43.48
  • NC 60.32
  • Support Level
  • CRBU $2.37
  • NC $30.00
  • Resistance Level
  • CRBU $2.08
  • NC $31.24
  • Average True Range (ATR)
  • CRBU 0.26
  • NC 1.11
  • MACD
  • CRBU -0.07
  • NC -0.13
  • Stochastic Oscillator
  • CRBU 6.42
  • NC 53.75

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

Share on Social Networks: